GoodRx Holdings, Inc. (GDRX)

2.735 -0.04 (-1.62%) USD  |  NASDAQ  |  Dec 18, 16:00
2.735 0.00 (0.00%) After-Hours: 20:00
More

GoodRx Holdings Research and Development Expense (TTM): 122.66M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for GDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Spok Holdings, Inc. 11.66M
DarioHealth Corp. 16.44M
National Research Corp. --
Axe Compute, Inc. --
Certara, Inc. 37.53M